Michael J. Rossi

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Princeton, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John LaRocca, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael J. Rossi

Form 4 holding Medical Group President

Mirion Technologies, Inc.

Security class
Class A Common Stock
Shares / value
116,173
Estimated value
$1,214,008
Report date
01 Nov 2023
Price
$10.45
Ownership
Direct
Form 4 holding PRESIDENT & CEO, Director

Y-mAbs Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
16 Sep 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Michael J. Rossi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .